- Conditions
- BPH (Benign Prostatic Hyperplasia), Lower Urinary Track Symptoms
- Interventions
- raloxifene, Finasteride
- Drug
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 242 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 49–72
of 184
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
- Interventions
- Prostatic artery embolization
- Device
- Lead sponsor
- Andrew Picel
- Other
- Eligibility
- 45 Years to 85 Years · Male only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Benign Prostate Hypertrophy(BPH), Lower Urinary Track Symptoms
- Interventions
- Device - HoLEP with MOSES 2.0, RWJA with Hydros Robotic System
- Device
- Lead sponsor
- The Methodist Hospital Research Institute
- Other
- Eligibility
- 50 Years to 80 Years · Male only
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2033
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- talaporfin sodium, Saline, Drug Activator 100 J/cm, Drug Activator 200 J/cm
- Drug · Device
- Lead sponsor
- Light Sciences Oncology
- Industry
- Eligibility
- 40 Years and older · Male only
- Enrollment
- 225 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 41
- States / cities
- Anniston, Alabama • Huntsville, Alabama • Anchorage, Alaska + 37 more
- Conditions
- Benign Prostatic Hypertrophy (BPH), Lower Urinary Track Symptoms
- Interventions
- Survey using a questionnaire.
- Other
- Lead sponsor
- Benaroya Research Institute
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Prostate Arterial Embolization
- Device
- Lead sponsor
- Antonios Likourezos
- Other
- Eligibility
- 35 Years to 99 Years · Male only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Brooklyn, New York
- Conditions
- BPH (Benign Prostatic Hyperplasia), BPH With Symptomatic Lower Urinary Tract Symptoms
- Interventions
- PuraStat hydrogel and the syringe
- Device
- Lead sponsor
- Endeavor Health
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Glenview, Illinois
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- QLT0074, Photodynamic therapy
- Drug
- Lead sponsor
- QLT Inc.
- Industry
- Eligibility
- Male only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2005
- U.S. locations
- 5
- States / cities
- San Francisco, California • Washington D.C., District of Columbia • New Port Richey, Florida + 2 more
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Embosphere Microspheres, HoLEP Procedure
- Device · Procedure
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Benign Prostatic Hyperplasia, Prostate Carcinoma
- Interventions
- Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis
- Other
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- Male only
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 2
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Neoplasms, Prostate
- Interventions
- dutasteride
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 2,795 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 73
- States / cities
- Anchorage, Alaska • Phoenix, Arizona • Little Rock, Arkansas + 68 more
- Conditions
- Benign Prostatic Hyperplasia, Urinary Tract Infections
- Interventions
- Nitrofurantoin, Cephalexin, Sulfamethoxazole Trimethoprim Combination, Ciprofloxacin, Holmium Laser Enucleation of prostate
- Drug · Procedure
- Lead sponsor
- Baylor Research Institute
- Other
- Eligibility
- 40 Years and older · Male only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 2
- States / cities
- Philadelphia, Pennsylvania • Temple, Texas
- Conditions
- Prostatic Hyperplasia
- Interventions
- Lemuteporfin for injection, Transurethral drug delivery system, Transurethral light delivery system
- Drug · Device
- Lead sponsor
- QLT Inc.
- Industry
- Eligibility
- 21 Years and older · Male only
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 8
- States / cities
- San Bernardino, California • Shreveport, Louisiana • Greenbelt, Maryland + 5 more
- Conditions
- Benign Prostatic Hyperplasia (BPH), Enlarged Prostate
- Interventions
- 2.5 mg NX-1207, 0.125 mg NX-1207, finasteride
- Drug
- Lead sponsor
- Nymox Corporation
- Industry
- Eligibility
- 45 Years to 75 Years · Male only
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 30
- States / cities
- Huntsville, Alabama • Tucson, Arizona • Little Rock, Arkansas + 27 more
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Placebo Tablet, Pomegranate Tablet
- Drug
- Lead sponsor
- University of California, Irvine
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2010
- U.S. locations
- 2
- States / cities
- Long Beach, California • Orange, California
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Medical Management, Surgical Management
- Other
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Glenview, Illinois
- Conditions
- Benign Prostate Hyperplasia
- Interventions
- Prolieve
- Device
- Lead sponsor
- Medifocus, Inc.
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2018
- U.S. locations
- 7
- States / cities
- Orlando, Florida • Roswell, Georgia • Shreveport, Louisiana + 4 more
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Silodosin, Placebo
- Drug · Other
- Lead sponsor
- Watson Pharmaceuticals
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 462 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 42
- States / cities
- Birmingham, Alabama • Carmichael, California • Fresno, California + 39 more
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Interventions
- Not listed
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 3,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2036
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Interventions
- Vortx Rx - Histotripsy BPH Device
- Device
- Lead sponsor
- HistoSonics, Inc.
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 2
- States / cities
- Ann Arbor, Michigan • Toledo, Ohio
- Conditions
- Overactive Bladder, Urinary Urgency Incontinence, Benign Prostatic Hyperplasia, Prostate Cancer, Prostatectomy, Urinary Frequency
- Interventions
- Axonics SNM System
- Device
- Lead sponsor
- Axonics, Inc.
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 23
- States / cities
- Birmingham, Alabama • Fairhope, Alabama • Scottsdale, Arizona + 20 more
- Conditions
- Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease, Prostate Hypertrophy, Prostate Pain, Lower Urinary Tract Symptoms, Urinary Obstruction, Urinary Tract Disease
- Interventions
- Finasteride
- Drug
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2026
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA) Therapy, Finasteride and Alfuzosin
- Device · Drug
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIH
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 49 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 7
- States / cities
- Denver, Colorado • Chicago, Illinois • Rochester, Minnesota + 4 more
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Placebo, tadalafil
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 325 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009
- U.S. locations
- 12
- States / cities
- Huntsville, Alabama • Middlebury, Connecticut • Sarasota, Florida + 9 more